Companies

Govt of Kazakhstan keen to join hands with Midhani to produce bio-implants

| Updated on June 18, 2019 Published on June 18, 2019

The Government of Kazakhstan has evinced interest in collaborating with MIDHANI to produce, on a commercial scale, bio-implants which have been beneficial to patients.

A team from the Hyderabad-based Midhani, a public sector undertaking, is in the former Soviet Union nation for discussions with UKTMP, a representative firm of the country, according to Dinesh Kumar Likhi, its Chairman & Managing Director.

Midhani, which is the main supplier of speciality materials for the defence, space and nuclear sectors, has made a range of bio-implants from titanium alloys and special grade stainless steel that have been certified by the Drug Controller of India.

Since 2001, the undertaking has been generating a revenue of a paltry Rs 1 crore on average, on account of business challenges as well as regulatory hurdles.

The market for titanium and stainless steel derived implants is estimated at Rs 1,000 crore, of which 50-60 per cent is accounted for by imports. Sensing the huge potential, Midhani has decided to focus on this vertical in collaboration with Hindustan Antibiotics Ltd (HAL), Lekhi told newspersons here today.

The two public sector undertakings signed a memorandum of understanding (MoU) at a function here. HAL, the Pune-headquartered antibiotics maker, with its nationwide dealer network and experience in pharma products, would be able to market these products well, said Nirja Saraf, its Managing Director.

Midhani makes over 130 types of implants, mostly using titanium alloys. These include shoulder prosthesis, hinged knee joints and total femur prosthesis.

The two firms are targeting a turnover of at least Rs 5 crore per annum to begin with. HAL will make the implants based on the high quality material that Midhani provides, and will market it through its network. The two partners have also decided to get the products tested and established scientifically, so that they can be pitched for export in the future.

A big challenge would be to bring down the cost of titanium alloy below that of the widely used stainless steel, and also convince medical practitioners about their efficacy and utility in the competitive market, Likhi said.

Published on June 18, 2019

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.